E-LIB Suche - Ergebnisse für: Fattah, Farjana J.

1

Distinct autoantibody profiles across checkpoint inhibitor ..:

Mu-Mosley, Hong ; von Itzstein, Mitchell S. ; Fattah, Farjana...
OncoImmunology. 13 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

2

Highly variable timing renders immunotherapy efficacy and t..:

von Itzstein, Mitchell S. ; Yang, Yuqiu ; Wang, Yiqing...
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

Systemic immune parameters after prior radiation therapy in..:

Mundra, Vatsala ; Yang, Yuqiu ; von Itzstein, Mitchell S....
Translational Oncology. 34 (2023) - p. 101689 , 2023

Link: https://doi.org/10.1016/..

4

Phase 1 trial of bemcentinib (BGB324), a first-in-class, se..:

Bhalla, Sheena ; Fattah, Farjana J. ; Ahn, Chul...
Lung Cancer. 182 (2023) - p. 107291 , 2023

Link: https://doi.org/10.1016/..

5

T-cell tolerant fraction as a predictor of immune-related a..:

Ostmeyer, Jared ; Park, Jason Y ; von Itzstein, Mitchell S...
Journal for ImmunoTherapy of Cancer. 11 (2023) 8 - p. e006437 , 2023

Link: https://doi.org/10.1136/..

6

Association between Antibiotic Exposure and Systemic Immune..:

von Itzstein, Mitchell S. ; Gonugunta, Amrit S. ; Sheffield, Thomas...
Cancers. 14 (2022) 5 - p. 1327 , 2022

Link: https://doi.org/10.3390/..

7

Divergent prognostic effects of pre-existing and treatment-..:

von Itzstein, Mitchell S. ; Gonugunta, Amrit S. ; Wang, Yiqing...
Cancer Immunology, Immunotherapy. 71 (2022) 9 - p. 2169-2181 , 2022

Link: https://doi.org/10.1007/..

8

Correction to: Divergent prognostic effects of pre-existing..:

von Itzstein, Mitchell S. ; Gonugunta, Amrit S. ; Wang, Yiqing...
Cancer Immunology, Immunotherapy. 71 (2022) 9 - p. 2183-2184 , 2022

Link: https://doi.org/10.1007/..

9

Association between body mass index, dosing strategy, and e..:

Ahmed, Murtaza ; von Itzstein, Mitchell S ; Sheffield, Thomas...
Journal for ImmunoTherapy of Cancer. 9 (2021) 6 - p. e002349 , 2021

Link: https://doi.org/10.1136/..

10

Humoral and cellular correlates of a novel immune-related a..:

Gonugunta, Amrit S ; von Itzstein, Mitchell S ; Mu-Mosley, Hong...
Journal for ImmunoTherapy of Cancer. 9 (2021) 12 - p. e003585 , 2021

Link: https://doi.org/10.1136/..

11

Late-Onset Immunotherapy Toxicity and Delayed Autoantibody ..:

Khan, Shaheen ; von Itzstein, Mitchell S. ; Lu, Rong...
The Oncologist. 25 (2020) 5 - p. e753-e757 , 2020

Link: https://doi.org/10.1634/..

12

Statin Intolerance, Anti-HMGCR Antibodies, and Immune Check..:

von Itzstein, Mitchell S. ; Khan, Shaheen ; Popat, Vinita...
The Oncologist. 25 (2020) 8 - p. e1242-e1245 , 2020

Link: https://doi.org/10.1634/..

13

XRN2 interactome reveals its synthetic lethal relationship ..:

Patidar, Praveen L. ; Viera, Talysa ; Morales, Julio C....
Scientific Reports. 10 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

14

XRN2 Depletion is Synthetic Lethal with PARP1 Inhibition:

Pay, Louise ; Motea, Edward E ; Patidar, Praveen...
The FASEB Journal. 33 (2019) S1 - p. , 2019

Link: https://doi.org/10.1096/..

15

Immune dysregulation in cancer patients developing immune-r..:

Khan, Shaheen ; Khan, Saad A. ; Luo, Xin...
British Journal of Cancer. 120 (2018) 1 - p. 63-68 , 2018

Link: https://doi.org/10.1038/..